Beacon Co - Net Worth and Insider Trading

Beacon Co Net Worth

The estimated net worth of Beacon Co is at least $0 dollars as of 2024-09-20. Beacon Co is the 10% Owner of Infinity Pharmaceuticals Inc and owns about 0 shares of Infinity Pharmaceuticals Inc (INFIQ) stock worth over $0. Details can be seen in Beacon Co's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Beacon Co has not made any transactions after 2013-04-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Beacon Co

To

Beacon Co Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Beacon Co owns 1 companies in total, including Infinity Pharmaceuticals Inc (INFIQ) .

Click here to see the complete history of Beacon Co’s form 4 insider trades.

Insider Ownership Summary of Beacon Co

Ticker Comapny Transaction Date Type of Owner
INFIQ Infinity Pharmaceuticals Inc 2013-04-16 10 percent owner

Beacon Co Latest Holdings Summary

Beacon Co currently owns a total of 1 stock. Beacon Co owns 0 shares of Infinity Pharmaceuticals Inc (INFIQ) as of April 16, 2013, with a value of $0.

Latest Holdings of Beacon Co

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
INFIQ Infinity Pharmaceuticals Inc 2013-04-16 0 0.00 0

Holding Weightings of Beacon Co


Beacon Co Form 4 Trading Tracker

According to the SEC Form 4 filings, Beacon Co has made a total of 0 transactions in Infinity Pharmaceuticals Inc (INFIQ) over the past 5 years. The most-recent trade in Infinity Pharmaceuticals Inc is the sale of 5,708,282 shares on April 16, 2013, which brought Beacon Co around $219 Million.

Insider Trading History of Beacon Co

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Beacon Co Trading Performance

GuruFocus tracks the stock performance after each of Beacon Co's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Beacon Co is 16.69%. GuruFocus also compares Beacon Co's trading performance to market benchmark return within the same time period. The performance of stocks bought by Beacon Co within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Beacon Co's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Beacon Co

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 29.47 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 30.77 LIMIT LIMIT LIMIT LIMIT LIMIT

Beacon Co Ownership Network

Ownership Network List of Beacon Co

No Data

Ownership Network Relation of Beacon Co

Insider Network Chart

Beacon Co Owned Company Details

What does Infinity Pharmaceuticals Inc do?

Who are the key executives at Infinity Pharmaceuticals Inc?

Beacon Co is the 10 percent owner of Infinity Pharmaceuticals Inc. Other key executives at Infinity Pharmaceuticals Inc include director & President & CEO Adelene Q Perkins , Chief Scientific Officer Stephane Peluso , and Chief Medical Officer Robert Jr. Ilaria .

Infinity Pharmaceuticals Inc (INFIQ) Insider Trades Summary

Over the past 18 months, Beacon Co made no insider transaction in Infinity Pharmaceuticals Inc (INFIQ). Other recent insider transactions involving Infinity Pharmaceuticals Inc (INFIQ) include a net sale of 410,196 shares made by Adelene Q Perkins ,

In summary, during the past 3 months, insiders sold 0 shares of Infinity Pharmaceuticals Inc (INFIQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 410,196 shares of Infinity Pharmaceuticals Inc (INFIQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 410,196 shares.

Infinity Pharmaceuticals Inc (INFIQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Infinity Pharmaceuticals Inc Insider Transactions

No Available Data

Beacon Co Mailing Address

Above is the net worth, insider trading, and ownership report for Beacon Co. You might contact Beacon Co via mailing address: C/o Whitely Chambers, Don Street, St. Helier, Jersey Channel Islands Xx Je4 9wg.

Discussions on Beacon Co

No discussions yet.